FDA Panel To Mull Abbott's Breakthrough Dissolving Stent
A U.S. Food and Drug Administration advisory panel is set Tuesday to consider the safety and proposed warning labels on the first heart stent designed to dissolve over time — which...To view the full article, register now.
Already a subscriber? Click here to view full article